Status:
RECRUITING
Insulin Therapy and Lipoproteins' Profile in Type 1 Diabetes.
Lead Sponsor:
Poznan University of Medical Sciences
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
18-35 years
Brief Summary
The aim of the study is to evaluate the effect of insulin therapy in patients with newly diagnosed type 1 diabetes on quantitative and qualitative changes of plasma lipoproteins, with particular empha...
Eligibility Criteria
Inclusion
- New onset type 1 diabetes and treatment with insulin.
- Written consent to participate in the study.
- There are no other medical conditions, and with no other additional drugs beyond insulin
Exclusion
- any other medical conditions, and any other additional drugs beyond insulin
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02306005
Start Date
November 1 2014
End Date
January 1 2028
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine and Diabetiology Poznan University of Medical Sciences
Poznan, Poland, 60-834